Form 8-K - Current report:
SEC Accession No. 0001193125-20-171447
Filing Date
2020-06-17
Accepted
2020-06-17 17:10:58
Documents
1
Period of Report
2020-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d948414d8k.htm 8-K 16217
  Complete submission text file 0001193125-20-171447.txt   17411
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

EIN.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38707 | Film No.: 20970477
SIC: 2836 Biological Products, (No Diagnostic Substances)